Growth Metrics

Invivyd (IVVD) Change in Receivables (2024 - 2025)

Invivyd posted quarterly Change in Receivables of $4.1 million for Q4 2025, up 47.82% year-on-year from $2.8 million in Q4 2024, and up 199.12% on a QoQ basis from $1.4 million in Q3 2025.

Invivyd (IVVD) has 2 years of Change in Receivables data on file, last reported at $4.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 47.82% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (down 69.4% YoY), and the FY2025 full-year result was $3.3 million, down 69.4% from the prior year.
  • Change in Receivables for Q4 2025 stood at $4.1 million, up from $1.4 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $5.3 million in Q3 2024 and bottomed at -$2.3 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 208,524.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -39.80 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 110.42 Mn
10 Invivyd 208.38 Mn -18.31 Mn - 4.07 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 4.07 Mn
Dec 31, 2025 4.07 Mn
Sep 30, 2025 1.36 Mn
Sep 30, 2025 1.36 Mn
Jun 30, 2025 254,000.00
Jun 30, 2025 254,000.00
Mar 31, 2025 -2.35 Mn
Mar 31, 2025 -2.35 Mn
Dec 31, 2024 2.75 Mn
Dec 31, 2024 2.75 Mn
Sep 30, 2024 5.27 Mn
Sep 30, 2024 5.27 Mn
Jun 30, 2024 2.89 Mn
Jun 30, 2024 2.89 Mn